These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38305329)

  • 1. Ultra-Processed Food, Disease Activity, and Inflammation in Ulcerative Colitis: The Manitoba Living With IBD Study.
    Vagianos K; Dolovich C; Witges K; Graff LA; Bernstein CN
    Am J Gastroenterol; 2024 Jun; 119(6):1102-1109. PubMed ID: 38305329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of Bidirectional Associations Between Perceived Stress and Symptom Activity: A Prospective Longitudinal Investigation in Inflammatory Bowel Disease.
    Sexton KA; Walker JR; Graff LA; Bernstein MT; Beatie B; Miller N; Sargent M; Targownik LE
    Inflamm Bowel Dis; 2017 Mar; 23(3):473-483. PubMed ID: 28221251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intake of Ultra-processed Foods Is Associated with an Increased Risk of Crohn's Disease: A Cross-sectional and Prospective Analysis of 187 154 Participants in the UK Biobank.
    Chen J; Wellens J; Kalla R; Fu T; Deng M; Zhang H; Yuan S; Wang X; Theodoratou E; Li X; Satsangi J
    J Crohns Colitis; 2023 Apr; 17(4):535-552. PubMed ID: 36305857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Relationship Among Perceived Stress, Symptoms, and Inflammation in Persons With Inflammatory Bowel Disease.
    Targownik LE; Sexton KA; Bernstein MT; Beatie B; Sargent M; Walker JR; Graff LA
    Am J Gastroenterol; 2015 Jul; 110(7):1001-12; quiz 1013. PubMed ID: 26077178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of ultra-processed food consumption with adult inflammatory bowel disease risk: a systematic review and dose-response meta-analysis of 4 035 694 participants.
    Babaei A; Pourmotabbed A; Talebi S; Mehrabani S; Bagheri R; Ghoreishy SM; Amirian P; Zarpoosh M; Mohammadi H; Kermani MAH; Fakhari H; Moradi S
    Nutr Rev; 2024 Jun; 82(7):861-871. PubMed ID: 37632227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease.
    Hoekman DR; Diederen K; Koot BG; Tabbers MM; Kindermann A; Benninga MA
    Eur J Pediatr; 2016 Oct; 175(10):1335-42. PubMed ID: 27573259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
    World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
    Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
    Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urgency for bowel movements is a highly discriminatory symptom of active disease in persons with IBD (the Manitoba Living with IBD study).
    Kulyk A; Shafer LA; Graff LA; Stone J; Witges K; Targownik LE; Bernstein CN
    Aliment Pharmacol Ther; 2022 Dec; 56(11-12):1570-1580. PubMed ID: 36225106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is moderate red wine consumption safe in inactive inflammatory bowel disease?
    Swanson GR; Tieu V; Shaikh M; Forsyth C; Keshavarzian A
    Digestion; 2011; 84(3):238-44. PubMed ID: 21876358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidimensional Impact of Mediterranean Diet on IBD Patients.
    Chicco F; Magrì S; Cingolani A; Paduano D; Pesenti M; Zara F; Tumbarello F; Urru E; Melis A; Casula L; Fantini MC; Usai P
    Inflamm Bowel Dis; 2021 Jan; 27(1):1-9. PubMed ID: 32440680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel Disease.
    Gracie DJ; Guthrie EA; Hamlin PJ; Ford AC
    Gastroenterology; 2018 May; 154(6):1635-1646.e3. PubMed ID: 29366841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the biological and clinical significance of fecal calprotectin in inflammatory bowel disease.
    Amati L; Passeri ME; Selicato F; Mastronardi ML; Penna A; Jirillo E; Covelli V
    Immunopharmacol Immunotoxicol; 2006; 28(4):665-81. PubMed ID: 17190742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal Human Neutrophil Peptide Levels Correlate with Intestinal Inflammation in Ulcerative Colitis.
    Kanmura S; Hamamoto H; Morinaga Y; Oda K; Fujita T; Arima S; Nasu Y; Sasaki F; Hashimoto S; Taguchi H; Setoyama H; Ido A
    Digestion; 2016; 93(4):300-8. PubMed ID: 27220673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal calprotectin correlated with endoscopic remission for Asian inflammatory bowel disease patients.
    Lin WC; Wong JM; Tung CC; Lin CP; Chou JW; Wang HY; Shieh MJ; Chang CH; Liu HH; Wei SC;
    World J Gastroenterol; 2015 Dec; 21(48):13566-73. PubMed ID: 26730169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid fecal calprotectin test for prediction of mucosal inflammation in ulcerative colitis and Crohn disease: a prospective cohort study.
    Moniuszko A; Głuszek S; Rydzewska G
    Pol Arch Intern Med; 2017 May; 127(5):312-318. PubMed ID: 28442699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid Fecal Calprotectin Test and Symptom Index in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.
    Puolanne AM; Kolho KL; Alfthan H; Ristimäki A; Mustonen H; Färkkilä M
    Dig Dis Sci; 2017 Nov; 62(11):3123-3130. PubMed ID: 28948412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
    Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
    World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis.
    Rokkas T; Portincasa P; Koutroubakis IE
    J Gastrointestin Liver Dis; 2018 Sep; 27(3):299-306. PubMed ID: 30240474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.